Chris Barton is a seasoned professional in the pharmaceutical industry, currently serving as Commercial Lead and Interim Director of Market Access and Public Affairs at Otsuka Pharmaceutical Co., Ltd. since August 2022, focusing on pricing and access strategies for hematology, nephrology, and mental health assets in the UK, Ireland, and Central and Eastern Europe. Previously, Chris held the position of Senior Director of Business Strategy at Vaniam Group Global Ltd, where engagement with global oncology and hematology clients helped develop impactful market solutions. Chris's extensive experience includes roles at Bedrock Healthcare Communications, Novartis, AbbVie, Baxter International Inc., and AstraZeneca, where significant achievements included team management through restructuring, strategy development, and creating innovative market access tools. Chris holds a BSc Hons in Physiology and Pharmacology from the University of Southampton.
This person is not in any teams
This person is not in any offices